Alseres Pharmaceuticals Inc. of Hopkinton has a securities purchase agreement for the private placement of $1 million worth of its stock, according to the company.
It will use the money for its research and development work, and for general corporate purposes.
The company develops drugs and diagnostic products for central nervous disorders. It is also working on molecular imaging program for diagnosing Parkinson’s disease and potentially dementia.
